• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于肝脏磁共振成像的造影剂。

Contrast agents for MR imaging of the liver.

作者信息

Balci N Cem, Semelka Richard C

机构信息

Department of Radiology, Saint Louis University, St. Louis, MO, USA.

出版信息

Radiol Clin North Am. 2005 Sep;43(5):887-98, viii. doi: 10.1016/j.rcl.2005.05.004.

DOI:10.1016/j.rcl.2005.05.004
PMID:16098345
Abstract

Imaging of the liver is performed most often to detect and characterize focal liver lesions. MR imaging has been the method of choice to assess focal liver lesions accurately. Nonspecific intravenous contrast agents have been used for routine abdominal MR imaging protocols including liver imaging. Over the last 10 to 15 years new contrast agents have been developed that combine the excellent contrast resolution of MR imaging with improved tissue specificity. This article reviews various contrast agents that are in clinical use for liver MR imaging and discusses their potential clinical role.

摘要

肝脏成像最常用于检测和表征肝脏局灶性病变。磁共振成像(MR成像)一直是准确评估肝脏局灶性病变的首选方法。非特异性静脉造影剂已用于包括肝脏成像在内的常规腹部MR成像方案。在过去10到15年中,已开发出新型造影剂,将MR成像出色的对比分辨率与更高的组织特异性相结合。本文综述了目前临床用于肝脏MR成像的各种造影剂,并讨论了它们潜在的临床作用。

相似文献

1
Contrast agents for MR imaging of the liver.用于肝脏磁共振成像的造影剂。
Radiol Clin North Am. 2005 Sep;43(5):887-98, viii. doi: 10.1016/j.rcl.2005.05.004.
2
Gadolinium-enhanced MR imaging of liver capsule and peritoneum.肝脏包膜和腹膜的钆增强磁共振成像。
Magn Reson Imaging Clin N Am. 2001 Nov;9(4):803-19, vii.
3
MR imaging of the liver. Contrast agents.肝脏的磁共振成像。造影剂。
Magn Reson Imaging Clin N Am. 1997 May;5(2):223-40.
4
Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver.钆螯合物在肝脏临床磁共振成像检查中的当前应用。
Top Magn Reson Imaging. 1998 Jun;9(3):141-66.
5
Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging.肝细胞癌:传统MRI表现,包括钆增强动态成像
Eur J Radiol. 2006 May;58(2):186-99. doi: 10.1016/j.ejrad.2005.11.039. Epub 2006 Jan 18.
6
[Status and development of new clinical contrast media for MR diagnosis of liver diseases].[用于肝脏疾病磁共振诊断的新型临床对比剂的现状与发展]
Radiologe. 1992 May;32(5):225-31.
7
Contrast-enhanced magnetic resonance imaging of the abdomen.
Magn Reson Q. 1994 Jun;10(2):97-124.
8
MR imaging of the liver using gadolinium chelates.使用钆螯合物对肝脏进行磁共振成像。
Magn Reson Imaging Clin N Am. 2001 Nov;9(4):717-43, vi.
9
MR imaging of the liver.肝脏的磁共振成像。
Radiol Clin North Am. 2005 Sep;43(5):861-86, viii. doi: 10.1016/j.rcl.2005.05.001.
10
MR imaging in the evaluation of hepatic metastases.
Magn Reson Imaging Clin N Am. 2000 Nov;8(4):741-56.

引用本文的文献

1
Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer.总胆红素水平可预测胆外胆管癌患者行钆塞酸增强 MRI 肝胆期时图像质量不佳。
Korean J Radiol. 2022 Apr;23(4):389-401. doi: 10.3348/kjr.2021.0407. Epub 2022 Jan 4.
2
Advances in functional and molecular MRI technologies in chronic liver diseases.慢性肝脏疾病的功能和分子 MRI 技术进展。
J Hepatol. 2020 Nov;73(5):1241-1254. doi: 10.1016/j.jhep.2020.06.020. Epub 2020 Jun 22.
3
Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy.
锰氧化物纳米颗粒作为肿瘤多模态成像和治疗的 MRI 对比剂。
Int J Nanomedicine. 2019 Oct 21;14:8321-8344. doi: 10.2147/IJN.S218085. eCollection 2019.
4
Respiratory motion in children and young adults undergoing liver magnetic resonance imaging with intravenous gadoxetate disodium contrast material.儿童和年轻成人在行静脉注射钆塞酸二钠对比磁共振成像时的呼吸运动。
Pediatr Radiol. 2019 Aug;49(9):1171-1176. doi: 10.1007/s00247-019-04437-x. Epub 2019 Jun 16.
5
Recent advances in non-invasive magnetic resonance imaging assessment of hepatocellular carcinoma.最近在非侵入性磁共振成像评估肝细胞癌方面的进展。
World J Gastroenterol. 2018 Jun 21;24(23):2413-2426. doi: 10.3748/wjg.v24.i23.2413.
6
Diagnostic value of Gd-EOB-DTPA-enhanced MR cholangiography in non-invasive detection of postoperative bile leakage.钆塞酸二钠增强磁共振胰胆管造影在术后胆漏无创检测中的诊断价值
Br J Radiol. 2017 Apr;90(1072):20160847. doi: 10.1259/bjr.20160847. Epub 2017 Feb 9.
7
Hepatocellular carcinoma 20 mm or smaller in cirrhosis patients: early magnetic resonance enhancement by gadoxetic acid compared with gadopentetate dimeglumine.肝硬化患者中直径20毫米及以下的肝细胞癌:与钆喷酸葡胺相比,钆塞酸二钠的早期磁共振增强表现
Hepatol Int. 2014 Jan;8(1):104-11. doi: 10.1007/s12072-013-9467-7. Epub 2013 Aug 17.
8
ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents.欧洲胃肠道和腹部放射学会关于肝脏磁共振成像及肝脏特异性对比剂临床应用的共识声明。
Eur Radiol. 2016 Apr;26(4):921-31. doi: 10.1007/s00330-015-3900-3. Epub 2015 Jul 21.
9
Comparison of gadoxetic acid and gadopentetate dimeglumine-enhanced MRI for HCC detection: prospective crossover study at 3 T.钆塞酸二钠与钆喷酸葡胺增强MRI在肝细胞癌检测中的比较:3T前瞻性交叉研究
Acta Radiol Open. 2015 Jan 19;4(2):2047981614561285. doi: 10.1177/2047981614561285. eCollection 2015 Feb.
10
Liver specific magnetic resonance imaging contrast medium for evaluation of focal liver lesions - Initial experience at a service hospital.用于评估肝脏局灶性病变的肝脏特异性磁共振成像造影剂——一家服务医院的初步经验
Med J Armed Forces India. 2012 Oct;68(4):350-5. doi: 10.1016/j.mjafi.2012.07.001. Epub 2012 Aug 20.